Nelly Kanberg, doctoral student at the Institute of Biomedicine and resident at Sahlgrenska University Hospital, is one of three recipients of a SEK 25,0000 scholarship from Pfizer and the Swedish Infectious Diseases Association. Nelly Kanberg’s doctoral project is about the link between SARS-CoV-2 and possible neurodegenerative effects that in the long run could lead to increased vulnerability to dementia diseases including Alzheimer’s disease. The scholarship was awarded at Infection Week and Microbiological Meeting Online on September 16, 2021. The other two scholarship recipients are Johanna Kuhlin (KI) who researches multi-resistant tuberculosis and Lisa Labbé Sandelin (Uppsala University) whose research is about unusual tick born diseases.